HomeInsightsPE

Rekvina Labs Ltd PE Ratio

Rekvina Labs Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 13, 2021)

stocks purchased

0.0 K

Stocks Traded

(Dec 13, 2021)

Last Updated on: Nov 24, 2024

Image

Rekvina Labs Ltd

NSE: REKVINALABS

PE

-

Last updated on: Nov 24, 2024

Key Highlights

  • The P/E Ratio of Rekvina Labs Ltd is 0 as of 24 Nov 09:01 AM .
  • The P/E Ratio of Rekvina Labs Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Latest Trading Price of Rekvina Labs Ltd is ₹ 4.5 as of 13 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Rekvina Labs Ltd

No data available

Company Fundamentals for Rekvina Labs Ltd

No data available

Image

Rekvina Labs Ltd

NSE: REKVINALABS

Share Price

₹ 4.5

0.00 (0.00%)

stock direction

Last updated on: Dec 13, 2024

Market Price of Rekvina Labs Ltd

1M

1Y

3Y

5Y

Monitoring Rekvina Labs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Dec 20214.5
25 Oct 20214.5
11 Oct 20214.3
04 Oct 20214.38
27 Sep 20214.18
13 Sep 20213.99
30 Aug 20213.8
26 Jul 20213.78
19 Jul 20213.78
05 Jul 20213.6

BlinkX Score for Rekvina Labs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Rekvina Labs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Rekvina Labs Ltd02
Sun Pharmaceuticals Industries Ltd384,31,352
Divis Laboratories Ltd861,59,265
Cipla Ltd261,20,033
Torrent Pharmaceuticals Ltd611,07,301
Mankind Pharma Ltd481,02,231

Key Valuation Metric of Rekvina Labs Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Rekvina Labs Ltd

No data available

* All values are in crore

Historical Revenue of Rekvina Labs Ltd

No data available

* All values are in crore

Historical EBITDA of Rekvina Labs Ltd

No data available

* All values are in crore

Historical Net Profit of Rekvina Labs Ltd

No data available

* All values are in crore

Historical Dividend Payout of Rekvina Labs Ltd

No data available

* All values are in %

About Rekvina Labs Ltd

  • Rekvina Labs Ltd was incorporated on 1st November 1988.
  • The Company is registered in England and Wales as a Public Limited Company.
  • The company is mainly engaged in manufacturing and marketing of pharmaceutical products.
  • It presently operates into one business segment i.e. copper extrusion. During FY2015, the company sub divided its existing equity shares in such a manner that every shareholder holding 1 equity share of Rs. 10/- each is issued 2 equity shares of Rs. 5/- each. During the year 2017, the Company issued a total of 10,769,867 shares.
  • Of this total, 9,043,518 shares were issued under the Mobeus VCTs' Linked Offer for Subscription launched on 10 December 2014; and 1,726,349 shares were issued under Company's Dividend Investment Scheme. During the year 2017, the Company bought back 553,800 of its own shares at an average price of 95.

Rekvina Labs Ltd News Hub

News

Rekvina Labs revises AGM Date

Rekvina Labs has revised the Annual General Meeting (AGM) of the company which was schedul...

Read more

2024-08-10 00:00:00

News

Rekvina Labs to conduct board meeting

Rekvina Labs will hold a meeting of the Board of Directors of the Company on 30 August 202...

Read more

2024-08-26 00:00:00

News

Rekvina Labs revises board meeting date

Rekvina Labs has revised the meeting of the Board of Directors which was scheduled to be h...

Read more

2024-08-31 00:00:00

News

Rekvina Labs AGM scheduled

Rekvina Labs announced that the Annual General Meeting (AGM) of the company will be held o...

Read more

2024-09-04 00:00:00

News

Rekvina Labs to table results

Rekvina Labs will hold a meeting of the Board of Directors of the Company on 14 November 2...

Read more

2024-11-08 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Rekvina Labs Ltd

What is the current PE Ratio of Rekvina Labs Ltd?

The Current PE Ratio of Rekvina Labs Ltd is 0.0 as on 24 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 24 Nov 2024.

What was the PE Ratio of Rekvina Labs Ltd last year?

The PE Ratio of Rekvina Labs Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Rekvina Labs Ltd indicate about its stock?

The PE Ratio of Rekvina Labs Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Rekvina Labs Ltd.

What is the PE Ratio Growth of Rekvina Labs Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Rekvina Labs Ltd grew by -% whereas, the EPS ratio grew by 1000.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*